Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia

Clinical trial NCT02274766 · COMPLETED

Trial details

NCT number: NCT02274766
Sponsor: Adamas Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dyskinesia Levodopa-Induced Dyskinesia (LID)Parkinson's Disease (PD)

Start date: 2014-10-01
Primary completion: 2016-03-10
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.